Investor Presentaiton
Globally since 2017, a Total of 34 CGT Therapies Have Received Their First-
time Approval
CGT drugs which obtained 1st time approval, including approvals from ex-US regulatory authorities since 2017
8
■Cell therapy (non-gene-modified)
Gene-modified cell therapy
7
Gene therapy
6
LO
4
3
2
1
0
LUXTURNA
GINTUIT
Delytact
Abecma
ADSTILADRIN
skysona
Upstaza
Elevidys
Relma-cel
HEMGENIX
Cetranacogene dezaparvovec-drib
Vyjuvek
KYMRIAH
HPC cord
blood
YESCARTA
(axicabtagene cila eucel)
Stemirac
Collategene
libmeldy™
Breyanzi
(atidarsagene autotemcel)
OrthoACIT
Stempeucel
2017
Source: Public information
2018
Rosmir
zynteglo
TECARTUS
StrataGraft™
ALOFISEL
zolgensma
Nepic
RETHYMIC™
2019
2020
2021
2022
ROCTAVIAN
Lantidra
EBVALLO
tabelecie cel
CARVYKTI
(citacabtagene autoleuce
Omisirge®
Vyznova
ビズノバ
2023
ニ 药明康德
Wuxi AppTecView entire presentation